| Hybrid Ablation of Persistent and Long-standing Persistent Stand-alone Atrial Fibrillation (NCT02832206) | Charles University, Czech Republic | 2016-03-01 |
| Vimecon CAI Trial for the Interventional Treatment of Paroxysmal Atrial Fibrillation (AF) (NCT02770989) | Vimecon GmbH | 2016-03-01 |
| Assessment of the Clinical Efficacy of the Heart Spectrum Blood Pressure Monitor for Diagnosis of Atrial Fibrillation (NCT03095131) | Ostar Meditech Corp | 2016-02-22 |
| Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf) (NCT03441633) | Pfizer | 2016-02-18 |
| Circulating BDNF in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise Training (NCT02627183) | Ottawa Heart Institute Research Corporation | 2016-02-16 |
| Real-world Comparative Effectiveness of Rivaroxaban Versus VKA (NCT02690155) | Bayer | 2016-02-12 |
| Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist (NCT02687854) | Bayer | 2016-02-12 |
| Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist (NCT02687867) | Bayer | 2016-02-12 |
| Real-world Dosing Patterns of Rivaroxaban in the United States (NCT03242278) | Bayer | 2016-02-12 |
| Atrial Fibrillation Patient Preference Study (NCT02611635) | Bayer | 2016-02-02 |
| Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study (NCT02450682) | Mayo Clinic | 2016-02-01 |
| Rate Control in Atrial Fibrillation II (NCT02695992) | Asker & Baerum Hospital | 2016-02-01 |
| Substrate Versus Trigger Ablation for Paroxysmal Atrial Fibrillation (NCT02169037) | University of California, San Diego | 2016-02-01 |
| Clinical Data Validation of Novel Wireless Cortrium C3 Monitor for Continuous Electrocardiogram Measurements (NCT02714907) | Cortrium | 2016-02-01 |
| BLITZ Atrial Fibrillation (NCT03653598) | Heart Care Foundation | 2016-02-01 |
| Pulmonary Vein Reconnection Following Ablation Index-guided Ablation: a Success Evaluation (NCT02628730) | Liverpool Heart and Chest Hospital NHS Foundation Trust | 2016-02-01 |
| Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients (NCT03444259) | University of Turku | 2016-02-01 |
| Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients (NCT02461602) | Duke University | 2016-02-01 |
| Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms (NCT02758002) | University of California, San Diego | 2016-01-28 |
| Catheter Ablation for Atrial Fibrillation in Preserved Ejection Fraction (NCT04317911) | University Hospital Heidelberg | 2016-01-26 |
| Clinical Decision Support for Stroke Prevention in Atrial Fibrillation (NCT02635685) | University Hospital, Linkoeping | 2016-01-11 |
| Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs (NCT02202967) | NHS Greater Glasgow and Clyde | 2016-01-07 |
| Retracting the Esophagus During AF Ablation (NCT02665442) | Northeast Scientific, Inc. | 2016-01-01 |
| Isolation of Pulmonary Veins With the Aid of Magnetic Resonance Imaging (NCT02698631) | Hospital Clinic of Barcelona | 2016-01-01 |
| Registration Study of Acute Ischemic Stroke/Transient Ischemic Attack (TIA) With Atrial Fibrillation (NCT04080830) | Xuanwu Hospital, Beijing | 2016-01-01 |
| A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics (NCT02345356) | University of Puerto Rico | 2016-01-01 |
| Keep it SIMPLE: Improving Anti-Coagulation Medication Adherence (NCT02690649) | Tammy Toscos | 2016-01-01 |
| Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation (NCT02666157) | National Cheng-Kung University Hospital | 2016-01-01 |
| Procedure RElated Outcomes With the Watchman FLX Left Atrial Appendage Closure Device (NCT03339193) | Oxford University Hospitals NHS Trust | 2016-01-01 |
| Comparison of His Bundle Pacing and Bi-Ventricular Pacing in Heart Failure With Atrial Fibrillation (NCT02805465) | First Affiliated Hospital of Wenzhou Medical University | 2016-01-01 |
| Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients (NCT02592980) | University of Sao Paulo General Hospital | 2016-01-01 |
| ATRIAL FIBRILATION OPPORTUNISTIC SCREENING AND STROKE (AFOSS). (NCT03589170) | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 2016-01-01 |
| Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN) (NCT02639793) | Heikki Huikuri | 2016-01-01 |
| AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation (NCT02341105) | Population Health Research Institute | 2016-01-01 |
| Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial (NCT02168829) | Ottawa Heart Institute Research Corporation | 2016-01-01 |
| Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA (NCT02657616) | Institut für Pharmakoökonomie und Arzneimittellogistik e.V. | 2015-12-01 |
| EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation (NCT02561897) | Electrophysiology Research Foundation | 2015-12-01 |
| A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation (NCT02789358) | Fundación para la Investigación del Hospital Clínico de Valencia | 2015-12-01 |
| Impact of a New Ablation Tracking Tool in Paroxysmal Atrial Fibrillation Ablation With Contact Force Technology (NCT02681926) | Giulio Zucchelli | 2015-12-01 |
| Coagulation Activity and Thrombogenesis in Patients With Atrial Fibrillation (NCT02451254) | Tel-Aviv Sourasky Medical Center | 2015-12-01 |
| The REACT-ICD Trial (NCT02439424) | Hartford Hospital | 2015-12-01 |
| Left Atrial Appendage Occlusion Registry (LAAO Registry) (NCT02699957) | American College of Cardiology | 2015-12-01 |
| Internet-based Cognitive Behavior Therapy for Atrial Fibrillation (NCT02694276) | Karolinska Institutet | 2015-12-01 |
| HeartLight Guided - Pure Pulmonary Vein Isolation Regardless of Concomitant Atrial Substrate (NCT02655731) | Cardioangiologisches Centrum Bethanien | 2015-12-01 |
| Cryoballoon and Associated Esophageal Effects (NCT03960346) | Baylor Research Institute | 2015-11-25 |
| Patient Convenience Study (NCT02597920) | Boehringer Ingelheim | 2015-11-11 |
| A Cross-sectional Study for the Determination of the Prevalence of Non-valvular Atrial Fibrillation Among Patients Diagnosed With Hypertension (NCT02585076) | Bayer | 2015-11-04 |
| Active Clearance of Chest Tubes After Cardiac Surgery: A Prospective Randomized Controlled Study (NCT02808897) | Montreal Heart Institute | 2015-11-01 |
| Dynamic Changes in SDF-1α Levels in Acute and Stabilized Heart Disease (NCT02702752) | Copenhagen University Hospital, Hvidovre | 2015-11-01 |
| Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation (NCT02608099) | Baim Institute for Clinical Research | 2015-11-01 |
| Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention (NCT02273700) | Centre Hospitalier Universitaire de Nīmes | 2015-11-01 |
| mHealth Screening to Prevent Strokes (NCT02506244) | Scripps Translational Science Institute | 2015-11-01 |
| Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation (NCT02734355) | Research Institute for Complex Problems of Cardiovascular Diseases, Russia | 2015-11-01 |
| Exercise Training in Patients With Atrial Fibrillation (OPPORTUNITY Study) (NCT02602457) | Ottawa Heart Institute Research Corporation | 2015-11-01 |
| Combining Left Atrial Appendage Closure With Cryoballoon Ablation in Chinese Population (NCT04185142) | Shanghai 10th People's Hospital | 2015-10-16 |
| Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation (NCT02426944) | Charles University, Czech Republic | 2015-10-13 |
| Burden of Illness in Atrial Fibrillation (NCT02615587) | Bayer | 2015-10-01 |
| First-line Treatment for Atrial Fibrillation in Cardiology and Geriatric Departments (NCT02884661) | Centre Hospitalier Régional Metz-Thionville | 2015-10-01 |
| Atrial Fibrillation Screening With a Smartphone Device and iECG Application (NCT02534532) | Bayer | 2015-10-01 |
| Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban (NCT02549963) | Shulin Wu | 2015-10-01 |
| Effect of Cryoballoon and RF Ablation on Left Atrial Function (NCT02611869) | G.Gennimatas General Hospital | 2015-10-01 |
| ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1 (NCT02569528) | Duke University | 2015-10-01 |
| Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies (NCT02610153) | Bayer | 2015-10-01 |
| Multi-Channel Esophageal ECG Signal Classification (NCT02541175) | Insel Gruppe AG, University Hospital Bern | 2015-10-01 |
| Assessing the Ability of Warfarin Treated Patients to Predict Their INR (NCT02764112) | Northeast Iowa Medical Education Foundation | 2015-10-01 |
| Postoperative Atrial Fibrillation Suppression By Nerve Stimulation (NCT03533140) | Medical University of Vienna | 2015-10-01 |
| Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon (NCT02591225) | University of Ulm | 2015-10-01 |
| WATCHMAN Implantation During Hybrid Ablation (NCT02471131) | Maastricht University Medical Center | 2015-10-01 |
| Changes in Cardiac Autonomic Nervous System Following Atrial Fibrillation Ablation. (NCT03811639) | Centre of Postgraduate Medical Education | 2015-10-01 |
| Pleotropic Effect of New Oral Anticoagulants (NCT02544932) | Kyunghee University Medical Center | 2015-10-01 |
| BIO.MASTER.BioMonitor 2 Study (NCT02565238) | Biotronik SE & Co. KG | 2015-09-01 |
| GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence (NCT02633982) | Japan Cardiovascular Research Foundation | 2015-09-01 |
| ELR Monitoring Against Permanent Pacemaker in Atrial Fibrillation (NCT02506621) | Eastbourne General Hospital | 2015-09-01 |
| Apixaban in Atrial Fibrillation Registry (NCT02563639) | IHF GmbH - Institut für Herzinfarktforschung | 2015-09-01 |
| An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers (NCT02559232) | Bayer | 2015-09-01 |
| Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery (NCT02498769) | Joseph Mathew, M.D. | 2015-09-01 |
| Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery (NCT02617069) | Meshalkin Research Institute of Pathology of Circulation | 2015-09-01 |
| Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF (NCT03061123) | Medical University of Graz | 2015-09-01 |
| Impact of Anxiety on Cardiac Substrate Modification in Women With Atrial Fibrillation Undergoing Catheter Ablation (NCT02547584) | Texas Cardiac Arrhythmia Research Foundation | 2015-09-01 |
| aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation (NCT02513797) | AtriCure, Inc. | 2015-09-01 |
| Foresight Intracardiac Echocardiography (ICE) System (NCT02514876) | Conavi | 2015-09-01 |
| Russian National Registry of LAAO (NCT04322474) | National Research Center for Preventive Medicine | 2015-09-01 |
| Reverse Prediction of Ion Channel Remodeling in Patients With Atrial Fibrillation Utilizing Monophasic Action Potential and Mathematical Modeling (NCT02414815) | Yonsei University | 2015-08-28 |
| Anticoagulation Preference by AF Patients Study (NCT02607371) | Bayer | 2015-08-27 |
| LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure (NCT04628078) | Insel Gruppe AG, University Hospital Bern | 2015-08-12 |
| D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy (NCT03280641) | Wuhan Asia Heart Hospital | 2015-08-09 |
| The Effect of Magnesium Therapy to Prevent Post-operative Atrial Fibrillation After Cardiac Surgery in Adults (NCT02928315) | Assiut University | 2015-08-01 |
| Stroke Lesion Pattern on MRI and Atrial Fibrillation (NCT02606890) | Charite University, Berlin, Germany | 2015-08-01 |
| The Ottawa AF Cardioversion Protocol (NCT02192957) | David Birnie | 2015-08-01 |
| Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation (NCT02944019) | Daiichi Sankyo | 2015-08-01 |
| Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation (NCT02067182) | Georg Nickenig | 2015-08-01 |
| Effects of Mindfulness on Atrial Fibrillation (NCT02564302) | Newmarket Electrophysiology Research Group Inc | 2015-08-01 |
| Utilizing a Novel Method to Map Sources of Atrial Fibrillation (NCT02523534) | Northwestern University | 2015-08-01 |
| PV Cryoablation Efficacy (COR ADVANCE Study) (NCT02588183) | Hospital San Carlos, Madrid | 2015-08-01 |
| Subclinical Postoperative Atrial Fibrillation (NCT02522364) | Sheba Medical Center | 2015-08-01 |
| Systematic Screening With Electrocardiogram for Unknown Atrial Fibrillation in 65 Years Old and Above People in Nursing Home (NCT02892578) | University Hospital, Montpellier | 2015-07-22 |
| SMART China, A Multi-center Clinical Registry Study (NCT02485925) | Biosense Webster, Inc. | 2015-07-01 |
| Bipolar Radiofrequency Ablation Plus Argon Beam Coagulator Ablation for Atrial Fibrillation (NCT02424110) | Xinqiao Hospital of Chongqing | 2015-07-01 |
| Post-Embolic Rhythm Detection With Implantable Versus External Monitoring (NCT02428140) | University of Alberta | 2015-07-01 |
| Laser Ablation Study for trEatment of atRial Fibrillation (LASER) (NCT02504567) | Hospital Clinic of Barcelona | 2015-07-01 |